8C5 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Coherus BioSciences Inc

Watchlist Manager

Watchlist

Price: 1.673 EUR 12.89%

Market Cap: €186.3m

C	Coherus BioSciences Inc SWB:8C5	US
	Atari SA PAR:ALATA	FR
S	STORE Capital Corp LSE:0LA6	US
N	Novartis AG BMV:NVSN	CH
	B3 Consulting Group AB (publ) F:B37	SE
M	Mirae Asset Securities Co Ltd KRX:006805	KR
A	Atlantia SpA F:AU9	IT
E	EVRAZ plc XBER:EVZ	UK
H	H World Group Ltd BMV:HTHTN	CN

Profitability Summary

Coherus BioSciences Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

67%

Strong 3Y Average Gross Margin

52%

Gross Margin is Increasing

58% > 67%

Negative Operating Margin

-410%

Negative 3Y Average Operating Margin

-173%

Declining Operating Margin

-130% > -410%

Exceptional Net Margin

398%

Strong 3Y Average Net Margin

35%

Net Margin is Increasing

-148% > 398%

Negative Free Cash Flow Margin

-328%

Negative 3Y Average Free Cash Flow Margin

-91%

Declining Free Cash Flow Margin

-140% > -328%

Negative ROE

-473%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-52%

ROIC is Increasing

-96% > -93%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.